rosiglitazone has been researched along with Hypertension, Renovascular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mandarim-de-Lacerda, CA; Mendonca, Lde S; Silva-Junior, Gde O; Torres, Tda S | 1 |
1 other study(ies) available for rosiglitazone and Hypertension, Renovascular
Article | Year |
---|---|
Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats.
Topics: Animals; Aorta; Carotid Artery, Common; Hypertension, Renovascular; Immunohistochemistry; Insulin; Leptin; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2011 |